Lymphoma

Lymphoma is one of the top ten common cancers in the Philippines, Among Filipino adults, incidence rate rises steeply starting age 50 among males and at age 55among females. Can lymphoma be treated? Minimally invasive technology has the advantages of few side effect, little trauma and quick recovery. With this cutting-edge technology, lymphoma patients can avoid the suffering of traditional chemotherapy and radiotherapy and prolong their life.


Types of lymphoma

There are two main types of lymphoma, that is, Hodgkin lymphoma and Non-Hodgkin lymphoma, of which the latter is more common. There are many types of Non-Hodgkin lymphoma and it is mainly divided into acute Non-Hodgkin lymphoma and chronic Non-Hodgkin lymphoma. Based on the cell type, it can be divided into cell B lymphoma and cell T lymphoma, while the former is more common.

Interpretation of Lymphoma Pathology Report

• What are the differences between Hodgkin lymphoma (HL) and Non-Hodgkin lymphoma (NHL)?

• What is diffuse cell B lymphoma?

• Why bone marrow aspiration is required when one is suspected to be afflicted with lymphoma?

Staging of lymphoma and 5-year survival rate (Statistics comes from American Cancer Society)

Stage I lymphoma: 90%,

Stage II lymphoma: 90%,

Stage III lymphoma: 80%,

stage IV lymphoma: 65%.

Prognosis of Non-Hodgkin lymphoma depends on the malignancy. Though lymphoma patients with low malignancy are not easy to be treated, 5-year survival rate can reach 70%. Lymphoma with high malignancy is highly invasive, thus the survival rate decreases as the stage goes up. About 30% to 40% lymphoma patients can maintain long-term survival after treatment.

Lymphoma Treatment

Torturous Traditional Anticancer technologies

Chemotherapy and Radiotherapy: severe toxic side effect, such as loss of hair and vomiting, etc.

New technologies to fight with lymphoma and improve survival rate effectively

Minimally invasive technology: 2-3 millimeter incision, few toxic effects and little pain.

 lymphoma, staging of lymphoma, interventional therapy, green chemotherapy, St. Stamford Modern Cancer Hospital Guangzhou

Interventional therapy: with a 1-2 millimeter incision, anti-cancer drugs are directly given to the tumor, causing fewer side effects and drug concentration is 2-8 times higher than systemic chemotherapy, killing cancer cells more accurately.

 lymphoma, staging of lymphoma, interventional therapy, green chemotherapy, St. Stamford Modern Cancer Hospital Guangzhou

Combination of TCM (Traditional Chinese Medicine) and western medicine: Combination of traditional Chinese medicine and minimally invasive techniques can not only kill the cancer cells effectively, but also reduce toxic side effects, lower the rate of cancer recurrence, and greatly improve survival rate.

 lymphoma, staging of lymphoma, interventional therapy, green chemotherapy, St. Stamford Modern Cancer Hospital Guangzhou

Green chemotherapy: Improved from traditional chemotherapy, green chemotherapy, avoiding the disadvantage of systematic chemotherapy, greatly improving curative effect and reducing toxic side effects, is a new generation of chemical weapons that kills tumors.

To know more cutting-edge technologies for treating lymphoma


Reservation Form
Patient's Name *
Cancer type *
Phone number *
Medical reports *
Go to Office


The MDT (Multidisciplinary Team) of St. Stamford Modern Cancer Hospital Guangzhou will make therapeutic plan for lymphoma patients based on their condition.

 lymphoma, staging of lymphoma, interventional therapy, green chemotherapy, St. Stamford Modern Cancer Hospital Guangzhou

MDT

Five advantages of treating lymphoma in St. Stamford Modern Cancer Hospital Guangzhou

• JCI International Medical Quality

• Advanced Anticancer Technology

• Professional Multidisciplinary Team (MDT)

• High Quality Medical Service

 Cozy and Comfortable Environment

Nursing and Diet for Lymphoma Patients

• Diet Care for Lymphoma Patients

• Three Principles of Home Care for Cancer Patients


Location of Offices
Frequently Asked Questions (FAQ)
Attend cancer symposiums
viber